These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24942913)

  • 21. Mesenchymal stem cell transplantation enhancement in myocardial infarction rat model under ultrasound combined with nitric oxide microbubbles.
    Tong J; Ding J; Shen X; Chen L; Bian Y; Ma G; Yao Y; Yang F
    PLoS One; 2013; 8(11):e80186. PubMed ID: 24244646
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mesenchymal stem cells enhanced cardiac nerve sprouting via nerve growth factor in a rat model of myocardial infarction.
    Chen J; Zheng S; Huang H; Huang S; Zhou C; Hou J; Jiang J; Wang J; Wu W; Wang T
    Curr Pharm Des; 2014; 20(12):2023-9. PubMed ID: 23844741
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mesenchymal stem cells overexpressing GCP-2 improve heart function through enhanced angiogenic properties in a myocardial infarction model.
    Kim SW; Lee DW; Yu LH; Zhang HZ; Kim CE; Kim JM; Park TH; Cha KS; Seo SY; Roh MS; Lee KC; Jung JS; Kim MH
    Cardiovasc Res; 2012 Sep; 95(4):495-506. PubMed ID: 22886775
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone-derived Nestin-positive mesenchymal stem cells improve cardiac function via recruiting cardiac endothelial cells after myocardial infarction.
    Lu D; Liao Y; Zhu SH; Chen QC; Xie DM; Liao JJ; Feng X; Jiang MH; He W
    Stem Cell Res Ther; 2019 Apr; 10(1):127. PubMed ID: 31029167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pre-treatment of mesenchymal stem cells with a combination of growth factors enhances gap junction formation, cytoprotective effect on cardiomyocytes, and therapeutic efficacy for myocardial infarction.
    Hahn JY; Cho HJ; Kang HJ; Kim TS; Kim MH; Chung JH; Bae JW; Oh BH; Park YB; Kim HS
    J Am Coll Cardiol; 2008 Mar; 51(9):933-43. PubMed ID: 18308163
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Guanxin Danshen Formulation improved the effect of mesenchymal stem cells transplantation for the treatment of myocardial infarction probably via enhancing the engraftment.
    Han XJ; Li H; Liu CB; Luo ZR; Wang QL; Mou FF; Guo HD
    Life Sci; 2019 Sep; 233():116740. PubMed ID: 31398416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Netrin-1 ameliorates myocardial infarction-induced myocardial injury: mechanisms of action in rats and diabetic mice.
    Ke T; Wu Y; Li L; Liu Y; Yao X; Zhang J; Kong D; Li C
    Hum Gene Ther; 2014 Sep; 25(9):787-97. PubMed ID: 24827071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Myocardial transfection of hypoxia-inducible factor-1α and co-transplantation of mesenchymal stem cells enhance cardiac repair in rats with experimental myocardial infarction.
    Huang B; Qian J; Ma J; Huang Z; Shen Y; Chen X; Sun A; Ge J; Chen H
    Stem Cell Res Ther; 2014 Feb; 5(1):22. PubMed ID: 24507665
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of interleukin-7 in fusion of rat bone marrow mesenchymal stem cells with cardiomyocytes in vitro and improvement of cardiac function in vivo.
    Haneef K; Ali A; Khan I; Naeem N; Jamall S; Salim A
    Cardiovasc Ther; 2018 Dec; 36(6):e12479. PubMed ID: 30451388
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Targeted migration of mesenchymal stem cells modified with CXCR4 gene to infarcted myocardium improves cardiac performance.
    Cheng Z; Ou L; Zhou X; Li F; Jia X; Zhang Y; Liu X; Li Y; Ward CA; Melo LG; Kong D
    Mol Ther; 2008 Mar; 16(3):571-9. PubMed ID: 18253156
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Over-expression of CXCR4 on mesenchymal stem cells augments myoangiogenesis in the infarcted myocardium.
    Zhang D; Fan GC; Zhou X; Zhao T; Pasha Z; Xu M; Zhu Y; Ashraf M; Wang Y
    J Mol Cell Cardiol; 2008 Feb; 44(2):281-92. PubMed ID: 18201717
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enhanced mesenchymal cell engraftment by IGF-1 improves left ventricular function in rats undergoing myocardial infarction.
    Enoki C; Otani H; Sato D; Okada T; Hattori R; Imamura H
    Int J Cardiol; 2010 Jan; 138(1):9-18. PubMed ID: 19411121
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adenosine Production by Biomaterial-Supported Mesenchymal Stromal Cells Reduces the Innate Inflammatory Response in Myocardial Ischemia/Reperfusion Injury.
    Shin EY; Wang L; Zemskova M; Deppen J; Xu K; Strobel F; García AJ; Tirouvanziam R; Levit RD
    J Am Heart Assoc; 2018 Jan; 7(2):. PubMed ID: 29331956
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transplantation with survivin-engineered mesenchymal stem cells results in better prognosis in a rat model of myocardial infarction.
    Fan L; Lin C; Zhuo S; Chen L; Liu N; Luo Y; Fang J; Huang Z; Lin Y; Chen J
    Eur J Heart Fail; 2009 Nov; 11(11):1023-30. PubMed ID: 19875403
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Co-treating mesenchymal stem cells with IL‑1β and TNF-α increases VCAM-1 expression and improves post-ischemic myocardial function.
    Wang CM; Guo Z; Xie YJ; Hao YY; Sun JM; Gu J; Wang AL
    Mol Med Rep; 2014 Aug; 10(2):792-8. PubMed ID: 24840001
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The enhanced effect and underlying mechanisms of mesenchymal stem cells with IL-33 overexpression on myocardial infarction.
    Chen Y; Zuo J; Chen W; Yang Z; Zhang Y; Hua F; Shao L; Li J; Chen Y; Yu Y; Shen Z
    Stem Cell Res Ther; 2019 Sep; 10(1):295. PubMed ID: 31547872
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mesenchymal stem cells conditioned with glucose depletion augments their ability to repair-infarcted myocardium.
    Choudhery MS; Khan M; Mahmood R; Mohsin S; Akhtar S; Ali F; Khan SN; Riazuddin S
    J Cell Mol Med; 2012 Oct; 16(10):2518-29. PubMed ID: 22435530
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pretreating mesenchymal stem cells with interleukin-1β and transforming growth factor-β synergistically increases vascular endothelial growth factor production and improves mesenchymal stem cell-mediated myocardial protection after acute ischemia.
    Luo Y; Wang Y; Poynter JA; Manukyan MC; Herrmann JL; Abarbanell AM; Weil BR; Meldrum DR
    Surgery; 2012 Mar; 151(3):353-63. PubMed ID: 22088815
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preconditioning mesenchymal stem cells with transforming growth factor-alpha improves mesenchymal stem cell-mediated cardioprotection.
    Herrmann JL; Wang Y; Abarbanell AM; Weil BR; Tan J; Meldrum DR
    Shock; 2010 Jan; 33(1):24-30. PubMed ID: 19996917
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Follistatin-like 1 protects mesenchymal stem cells from hypoxic damage and enhances their therapeutic efficacy in a mouse myocardial infarction model.
    Shen H; Cui G; Li Y; Ye W; Sun Y; Zhang Z; Li J; Xu G; Zeng X; Zhang Y; Zhang W; Huang Z; Chen W; Shen Z
    Stem Cell Res Ther; 2019 Jan; 10(1):17. PubMed ID: 30635025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.